- Home
- NFG vs CORT Comparison
NFG vs CORT Comparison
Compare NFG & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NFG | CORT |
|---|---|---|
| Founded | 1902 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 3.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NFG | CORT |
|---|---|---|
| Price | $82.67 | $36.38 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $91.20 | ★ $111.00 |
| AVG Volume (30 Days) | 790.4K | ★ 3.0M |
| Earning Date | 01-28-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.65% | N/A |
| EPS Growth | ★ 576.19 | N/A |
| EPS | ★ 5.68 | 0.87 |
| Revenue | ★ $2,277,541,000.00 | $741,172,000.00 |
| Revenue This Year | $14.20 | $21.70 |
| Revenue Next Year | $25.41 | $30.13 |
| P/E Ratio | ★ $14.24 | $40.40 |
| Revenue Growth | 17.11 | ★ 17.92 |
| 52 Week Low | $67.11 | $32.99 |
| 52 Week High | $94.13 | $117.33 |
Technical Indicators
Market Signals| Indicator | NFG | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 59.14 | 24.35 |
| Support Level | $77.80 | $34.06 |
| Resistance Level | $81.95 | $37.48 |
| Average True Range (ATR) | 1.78 | 2.23 |
| MACD | 0.29 | -0.12 |
| Stochastic Oscillator | 80.67 | 58.56 |
Price Performance
Historical ComparisonAbout NFG National Fuel Gas Company
National Fuel Gas Co is a diversified energy company engaged in the production, gathering, transportation, distribution, and marketing of natural gas. The operating segments of the company are the Exploration and Production segment, the Pipeline and Storage segment, the Gathering segment, and the Utility segment. The company generates a majority of its revenue from the Exploration and Production segment which is engaged in the exploration for, and the development and production of, natural gas in the Appalachian region of the United States. Geographically, the company operates in the United States.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.